Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000220

Director sold 28,000 shares at $60.00 ($1,680,000)

  • Director acquired 28,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

KLEIN JOSEPH III · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-03 Exercise or conversion : show line 1 in the form 10b5-1 +16,000 16,000 I
2025-09-03 Exercise or conversion : show line 2 in the form 10b5-1 +12,000 28,000 I
2025-09-03 Sale : show line 3 in the form 10b5-1 −28,000 $60.00 $1,680,000 0 I
Open-market sales · 28,000 sh · avg $60.00 · $1,680,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-09-03 Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −12,000 0 I
2025-09-03 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −16,000 0 I
Loading xslF345X05/edgardoc.xml…